Monitoring report · published · reflects the rules at that date

Upcoming updates to the UK Cosmetics Regulation – Methyl-N-methylanthranilate, HAA299 and HAA299 (nano)

Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.

See what happens after launch

On 28 April 2023, the United Kingdom (UK) notified the World Trade Organization (WTO) of a draft amendment to the Cosmetics Regulation 1223/2009, as applicable in Great Britain (i.e., England, Wales, and Scotland).

Methyl-N-methylanthranilate (M-N-MA) (CAS No 85-91-6) 

The fragrance ingredient, Methyl-N-methylanthranilate, is included in Annex III/321 (list of substances which cosmetic products must not contain except subject to the restrictions laid down)

  • 0.1% max. in leave-on products but not to be used in sunscreen products and products intended for exposure to natural or artificial UV light.
  • 0.2% max. in rinse-off products.
  • In both cases: Do not use with nitrosating agents, Maximum nitrosamine content: 50 µg/kg, Keep in nitrite-free containers.

HAA299 (CAS No 919803-06-8)

Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (HAA299) is included in Annex VI/33 (list of UV filters allowed in cosmetic products).

  • 10% max.
  • In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10%.

HAA299 (nano) (CAS No 919803-06-8)

Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano)/ HAA299 (nano) is included in Annex VI/34 (list of UV filters allowed in cosmetic products).

  • Only nanomaterials having the following characteristics are allowed:
    • Purity ≥ 97 %,
    • Median particle size D50 (50 % of the number below this diameter): ≥50 nm of number size distribution.
  • Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
  • In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10%.

Timeline:

  • Restrictions on Methyl-N-methylanthranilate: products not in accordance with the new changes will not be able to be placed on the market on or after 6 July 2024, however, a transition provision will allow them to be made available until 6 July 2026, after which any supply will be unlawful.
  • Restrictions on HAA299 and HAA299 (nano) will enter into force on 28 July 2023.

References:

World Trade Organization (WTO) – Committee on Technical Barriers to Trade – G/TBT/N/GBR/61, 28 April 2023

Need to know what this means for a product you have on the market now?

Ask the team for this area

One question works best. Leave out confidential product details; we can take those up by email.

Our team replies to every question. The reply goes to the email you gave.

We use your email to answer this question and for nothing else. Privacy and cookies

Follow an area

One email when an area publishes, in the language you choose. Nothing else.

Talk to us

Tell us the product, the market and the date you are working to. If the date is not realistic, we will say so.

Need a standing regulatory partner? See ongoing support →